COPT Defense Properties (NYSE:CDP) Receives Average Recommendation of “Moderate Buy” from Brokerages

COPT Defense Properties (NYSE:CDP) has earned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $33.6250.

Several analysts have recently commented on the stock. Evercore ISI reiterated an “outperform” rating on shares of COPT Defense Properties in a report on Friday, February 6th. Cantor Fitzgerald increased their price objective on shares of COPT Defense Properties from $33.00 to $37.00 and gave the company an “overweight” rating in a research note on Monday, February 9th. Jefferies Financial Group lifted their target price on shares of COPT Defense Properties from $33.00 to $34.00 and gave the stock a “buy” rating in a research report on Tuesday, January 27th. Citigroup boosted their target price on COPT Defense Properties from $29.00 to $34.00 and gave the stock a “neutral” rating in a research note on Tuesday. Finally, Wells Fargo & Company upped their target price on COPT Defense Properties from $30.00 to $33.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th.

Institutional Investors Weigh In On COPT Defense Properties

Large investors have recently made changes to their positions in the business. Norges Bank bought a new stake in shares of COPT Defense Properties during the 2nd quarter worth $39,371,000. Alliancebernstein L.P. increased its holdings in COPT Defense Properties by 16.8% during the third quarter. Alliancebernstein L.P. now owns 8,457,373 shares of the company’s stock worth $245,771,000 after buying an additional 1,215,936 shares during the last quarter. GRS Advisors LLC bought a new stake in COPT Defense Properties in the third quarter worth about $28,399,000. Two Sigma Investments LP raised its position in COPT Defense Properties by 289.9% in the third quarter. Two Sigma Investments LP now owns 900,047 shares of the company’s stock worth $26,155,000 after acquiring an additional 669,181 shares during the period. Finally, Ameriprise Financial Inc. boosted its stake in COPT Defense Properties by 323.0% in the third quarter. Ameriprise Financial Inc. now owns 791,867 shares of the company’s stock valued at $23,013,000 after acquiring an additional 604,670 shares during the last quarter.

COPT Defense Properties Stock Performance

Shares of CDP opened at $31.55 on Friday. COPT Defense Properties has a one year low of $23.92 and a one year high of $32.78. The company has a market cap of $3.57 billion, a PE ratio of 23.37 and a beta of 0.86. The stock has a 50-day moving average of $29.74 and a 200-day moving average of $29.22. The company has a debt-to-equity ratio of 1.77, a current ratio of 3.95 and a quick ratio of 2.34.

COPT Defense Properties (NYSE:CDP) last released its quarterly earnings data on Thursday, February 5th. The company reported $0.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.68 by $0.02. COPT Defense Properties had a net margin of 19.94% and a return on equity of 9.82%. The firm had revenue of $197.36 million for the quarter, compared to analyst estimates of $188.79 million. During the same period last year, the firm earned $0.65 earnings per share. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. COPT Defense Properties has set its FY 2026 guidance at 2.710-2.790 EPS and its Q1 2026 guidance at 0.670-0.690 EPS. On average, equities research analysts predict that COPT Defense Properties will post 2.67 EPS for the current fiscal year.

About COPT Defense Properties

COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.